Summary & Overview
CPT 80327: Anabolic Steroid Detection or Quantification
CPT code 80327 identifies a laboratory toxicology assay that measures or detects one or two anabolic steroids in a patient specimen. This test is used in clinical and forensic settings to identify use or exposure to synthetic androgenic agents and can inform clinical management, occupational testing, sports medicine, and compliance monitoring. Nationally, accurate coding for this specialized laboratory service affects claim processing, clinical documentation, and surveillance of performance and misuse trends.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical sites of service, and the clinical context for ordering this assay. The publication provides benchmarks and payer coverage context where available, notes common billing modifiers, and highlights coding considerations relevant to laboratories and billing professionals.
The piece is intended to help billing staff, laboratory managers, and policy analysts understand the clinical purpose and billing classification of CPT code 80327, how it fits within laboratory toxicology services, and what to expect in payer interactions and claims adjudication.
Billing Code Overview
CPT code 80327 describes a laboratory test in which a lab analyst measures the amount of or detects the presence of one or two anabolic steroids — synthetic drugs related to the male sex hormone testosterone — in a patient specimen. This service is a toxicology/therapeutic drug monitoring assay focused on anabolic steroid detection and quantification.
-
Service type: Laboratory toxicology testing for anabolic steroids
-
Typical site of service: Clinical laboratory or hospital laboratory collection site
Clinical & Coding Specifications
Clinical Context
A 28-year-old male competitive athlete is referred by his team physician for urine testing after a performance enhancement screening flagged possible anabolic steroid use. The laboratory receives a spot urine specimen, logs patient identifiers, and performs specimen accessioning. The lab analyst conducts targeted mass spectrometry or immunoassay testing to detect and/or quantify one or two anabolic steroids or their metabolites. Results are reviewed by the laboratory director, documented in the laboratory information system, and a report is sent to the ordering clinician. Chain-of-custody procedures are used when testing is ordered for doping control or legal/forensic purposes. Typical sites of service include hospital outpatient laboratories, independent diagnostic laboratories, sports medicine clinics, occupational health clinics, and forensic/toxicology laboratories.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard reporting | Use when no additional modifier applies to the service. |
26 | Professional component | Use when billing only the professional interpretation/consultative portion if separated from the technical component. |